NASDAQ$IVVD
Invivyd Inc · Q3 2025 earnings
Q3 2025 earnings · · Before market open · Investor relations
Briefing
Invivyd reported Q3 2025, revenue of $5M, net loss of $45M, diluted EPS of $-0.42.
For Q3 2025, Invivyd reported revenue of $5M, a net loss of $45M, diluted EPS was $-0.42. Management discusses operations, liquidity, and outlook in the quarterly filing.
- Revenue $5M.
- Net loss $45M.
- Diluted EPS $-0.42.
Headline financials
Revenue & EPS history
Invivyd · Revenue · Quarterly
$13.1M
Forward guidance
The filing discusses Invivyd's outlook, including capital allocation, operating priorities, and market risks relevant to the reported quarter.
Tailwinds
- Invivyd cites operational priorities and demand trends supporting the outlook.
- Balance sheet and liquidity actions aim to fund growth and returns.
Headwinds
- GAAP profitability remained under pressure in Q3 2025.
- Macro, pricing, and input-cost volatility could pressure margins.
- Segment mix and one-time items may affect quarter-to-quarter comparability.
- Clinical, regulatory, or liquidity milestones dominate the near-term outlook.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q3 2025
-1.7%
Avg return
Earnings day
-1.3%
Avg return
5 days after
-16.8%
Avg return
30 days after
53%
10 / 19 earnings
Positive
+18.4%
Q4 2021
Best reaction
-21.6%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -21.6% | -30.4% | -48.5% | |
| Q4 2025 | +2.4% | +7.0% | -25.1% | |
| Q3 2025 | +1.3% | +8.6% | +46.7% | |
| Q1 2025 | -15.8% | -3.2% | -5.3% | |
| Q4 2024 | +2.6% | -8.3% | -29.2% | |
| Q3 2024 | -15.2% | -13.8% | -38.5% | |
| Q2 2024 | -1.9% | -13.9% | +8.5% | |
| Q1 2024 | -10.7% | -4.0% | -33.2% | |
| Q4 2023 | +6.3% | +1.8% | -49.8% | |
| Q3 2023 | -7.9% | -1.3% | +11.8% | |
| Q2 2023 | +2.6% | +5.1% | +13.5% | |
| Q1 2023 | +1.4% | +5.6% | -8.5% | |
| Q4 2022 | -7.7% | -4.9% | -19.0% | |
| Q3 2022 | +8.8% | +6.3% | -40.2% | |
| Q2 2022 | -2.5% | +5.3% | +9.8% | |
| Q1 2022 | +7.9% | +10.9% | +11.3% | |
| Q4 2021 | +18.4% | +13.8% | -25.7% | |
| Q3 2021 | +5.5% | +4.9% | -66.8% | |
| Q2 2021 | -7.0% | -15.0% | -30.5% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro